Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis

Alimentary Pharmacology and Therapeutics

Volumn 36, Issue 1, 2012, Pages 16-21

  Vine, L J ^a   Shepherd, K ^a   Hunter, J G ^a   Madden, R ^a   Thornton, C ^a   Ellis, V ^a   Bendall, R P ^a,b   Dalton, H R ^a,b  

^a ROYAL CORNWALL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEPATITIS; ADULT; AGED; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EPSTEIN BARR VIRUS INFECTION; FEMALE; FEVER; HUMAN; INFECTIOUS MONONUCLEOSIS; JAUNDICE; LYMPHADENOPATHY; LYMPHOCYTOSIS; MALE; PATIENT ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SORE THROAT; SPLENOMEGALY; VIRUS HEPATITIS;

EID: 85027934906     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05122.x     Document Type: Review

References (20)

1. Epstein MA, Achong BG, Barr YM,. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702-3.
2. Drebber U, Kasper HU, Krupacz J, et al,. The role of Epstein-Barr virus in acute and chronic hepatitis. J Hepatol 2006; 44: 879-85.
3. Kang MJ, Kim TH, Shim KN, et al,. Infectious mononucleosis hepatitis in young adults: two case reports. Korean J Intern Med 2009; 24: 381-7.
4. Andersson JP,. Clinical aspects on Epstein-Barr virus infection. Scand J Infect Dis Suppl 1991; 80: 94-104.
5. Markin RS,. Manifestations of Epstein-Barr virus-associated disorders in liver. Liver 1994; 14: 1-13.
6. Yin CC, Medeiros LJ, Abruzzo LV, Jones D, Farhood AI, Thomazy VA,. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient. Am J Clin Pathol 2005; 123: 222-8.
7. Sánchez F, Gimeno-Bayõn JL, Esgueva R, Alvarez F, Munné MA, Serrano S,. Fatal liver failure: molecular evidence for chronic active Epstein-Barr virus infection. Ann Diagn Pathol 2008; 12: 368-71.
8. Papatheodoridis GV, Delladetsima JK, Kavallierou L, Kapranos N, Tassopoulos NC,. Fulminant hepatitis due to Epstein-Barr virus infection. J Hepatol 1995; 23: 348-50.
9. Hinedi TB, Koff RS,. Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult. Dig Dis Sci 2003; 48: 539-41.
10. Mason WR Jr, Adams EK,. Infectious mononucleosis; an analysis of 100 cases with particular attention to diagnosis, liver function tests and treatment of selected cases with prednisone. Am J Med Sci 1958; 236: 447-59.
11. Canovic P, Gajović O, Todorović Z, Mijailović Z,. Epstein-Barr virus hepatitis associated with icterus-a case report. Med Pregl 2006; 4: 179-82.
12. Edoute Y, Baruch Y, Lachter J, Furman E, Bassan L, Assy N,. Severe cholestatic jaundice induced by Epstein-Barr virus infection in the elderly. J Gastroenterol Hepatol 1998; 13: 821-4.
13. Park MJ, Chung IK, Park YD, et al,. A case of cholestatic hepatitis induced by Epstein-Barr virus infection. Korean J Hepatol 2006; 12: 237-42.
14. Mitchell J, Hussaini SH, McGovern DP, Farrow R, Maskell G, Dalton HR,. The "jaundice hotline" for the rapid assessment of patients with jaundice. BMJ 2002; 325: 213-5.
15. Shaw NJ, Evans JH,. Liver failure and Epstein-Barr virus infection. Arch Dis Child 1988; 63: 432-3.
16. Jenson HB,. Acute complications of Epstein-Barr virus infectious mononucleosis. Curr Opin Pediatr 2000; 12: 263-8.
17. Hess RD,. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol 2004; 42: 3381-7.
18. Jacobson IM, Gang DL, Schapiro RH,. Epstein-Barr viral hepatitis: an unusual case and review of the literature. Am J Gastroenterol 1984; 79: 628-32.
19. Dalton HR, Fellows HJ, Stableforth W, et al,. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007; 26: 1429-35.
20. Kamar N, Bendall R, Legrand-Abravanel F, et al,. Hepatitis E. Lancet 2012; in press.